patient
Outcomes of Adding a Fourth Chemotherapy Course in AML
Severe Aplastic Anemia and PNH Diagnoses Came out of Nowhere - Marianna's Story
Person's Name:
Marianna De Leon
As a typical community college student, Mariana was busy. Classes, studying, day trips, all were part of her life. Yet during one shower, she dropped to the floor, suddenly dizzy. A few weeks later she would be out of breath, with unusual bruises on her skin.
Bone Marrow Disease(s):
Content source:
Ivosidenib and Azacitidine Combination Demonstrates Durable Activity in Newly Diagnosed AML
Precision Medicine Approach Deemed Safe, Feasible for Older Patients With Untreated AML
Pegcetacoplan Bests Eculizumab for PNH Patients
Results from the phase III PEGASUS trial suggest that the targeted C3 inhibitor pegcetacoplan improved hemoglobin levels better than eculizumab in patients with
Overcoming Clinical Challenges Associated With TP53-Mutant MDS, AML
Guadecitabine Maintenance Therapy Shows Promise in High Risk MDS/AML Patients
GTB-3550 TriKE Stimulates Natural Killer Cell Function in MDS and AML
Bone Marrow Transplant Recipients During Childhood at Increased Risk for Severe Chronic Health Conditions
Patients who underwent allogeneic bone marrow transplantation (BMT) as children were at increased risk for severe or life-threatening chronic health conditions. These findings were presented during the American Society of Hematology (ASH) 62nd Annual Meeting and Exposition.